Par Pharma gets FDA approval for generic Ultram ER (AP)

November 23rd, 2009

AP – Par Pharmaceutical Co. said Monday it received marketing approval for a generic version of Johnson & Johnson’s extended-release chronic pain drug Ultram ER, and has started shipping the drug.

Related posts:

  1. Caraco gets FDA approval for generic Eloxatin (AP)
  2. Teva gets FDA approval for generic Prevacid (AP)
  3. KV sells generic drug application to Perrigo (AP)
  4. Generic drugmaker Teva names Frost as chairman (AP)
  5. Astra boosts generic exposure with Torrent deal (AP)
  6. Onyx Pharma will pay up to $851M for Proteolix (AP)
  7. BioCryst Pharma to sell up to 5.75M new shares (AP)
  8. EU says investigators raid pharma giants (AFP)
  9. Astellas Pharma plans $3.5B takeover bid for OSI (AP)
  10. Ex-pharma executive runs as Dem for Kan. governor (AP)
Tags:

Related posts

  • No related posts.

Posted in business | No Comments »

Comments

dedicated servers

Leave a Reply

You must be logged in to post a comment.